BRCA1 and ovarian cancer: They have observed a correlation between the acquisition of BRCA1/2 reversion mutations and resistance to therapy, suggesting that these mutations may have potential utility in predicting the chemotherapy response of ovarian cancer and subsequently informing treatment strategies for this disease.